Report Highlights Effective State Strategies to Improve Lead Screening and Treatment in Children

More than 535,000 children in the United States under age five have high blood lead levels, and low-income and minority children who live in older housing are particularly at risk. This issue brief details the health impacts of lead toxicity in children and Centers for Medicare & Medicaid Services requirements for screening and treatment under Medicaid and the Children’s Health Insurance Program. It highlights several effective state strategies to improve screening and treatment of lead toxicity in children.

Read the report: Lead Screening and Treatment Services under Medicaid and CHIP


This work is supported by the Health Resources and Services Administration (HRSA) of the Department of Health and Human Services (HHS) under grant number UC4MC28037 Alliance for Innovation on Maternal and Child Health: Expanding Access to Care for the Maternal and Child Health Population.